Jiajun Ding
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Design, synthesis and antiproliferative activity of pyridone derivatives as potent enhancer of zeste homologue 2/histone deacetylase dual inhibitors.
Journal: RSC advances
Published: June 05, 2026
Dual faces of USP10 in breast cancer: Oncogenic driver, tumor suppressor, and emerging therapeutic target.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 30, 2025
Development and Validation of a New Immune-Inflammatory-Nutritional Score to Predict Pathological Complete Response in Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Two-Center Study.
Journal: Journal of inflammation research
Published: March 18, 2025
Correlation of Cell-in-Cell Structure With Prognosis in Solid Tumors-A Meta-Analysis.
Journal: BioMed research international
Published: October 28, 2024
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions.
Journal: Cancer letters
Published: March 04, 2024
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 19, 2023
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.
Journal: Protein & cell
Published: August 03, 2023
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.
Journal: Signal transduction and targeted therapy
Published: June 06, 2022
TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer.
Journal: Nature communications
Published: September 23, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026